Patent ID: 8735357
Filing Date: 2014-05-27
Classification: A61K,A61P,C12N

Abstract:
1. A method for inducing antigen-specific T cells in a patient in need thereof, comprising administering intradermally at the same site to the patient a composition (a) which comprises a therapeutically effective amount of a peptide fragment consisting of Arg Met Phe Pro Asn Ala Pro Tyr Leu (SEQ ID NO: 2) or Cys Tyr Thr Trp Asn Gln Met Asn Leu (SEQ ID NO: 4) as an active ingredient and a composition (b) which comprises a therapeutically effective amount of IFN-α as an active ingredient, wherein the composition (b) is administered to the patient about 24 hours prior to administering the composition (a).